Modulation of type 1 diabetes susceptibility by tumor necrosis factor alpha -308 G/A and lymphotoxin alpha +249 A/G haplotypes and lack of linkage disequilibrium with predisposing DQB1-DRB1 haplotypes in bahraini patients

Clinical and Vaccine Immunology

Volumn 15, Issue 2, 2008, Pages 379-381

  Stayoussef, Mouna ^a   Al Jenaidi, Fayza A ^b,c   Al Abbasi, Abduljabbar ^b,c   Al Ola, Khadija ^c   Khayyat, Haya ^d   Mahjoub, Touhami ^a   Almawi, Wassim Y ^b  

^a UNIVERSITY OF MONASTIR   (Tunisia)

^b ARABIAN GULF UNIVERSITY   (Bahrain)

^c Salmaniya Medical Complex ^*  (Bahrain)

^d BAHRAIN DEFENSE FORCE HOSPITAL   (Bahrain)

Author keywords

[No Author keywords available]

Indexed keywords

LYMPHOTOXIN; TUMOR NECROSIS FACTOR ALPHA; HLA DQ ANTIGEN; HLA DQBETA ANTIGEN; HLA-DQBETA ANTIGEN; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; BAHRAIN; CONTROLLED STUDY; DISEASE PREDISPOSITION; DQB1 GENE; DRB1 GENE; FEMALE; GENE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SCHOOL CHILD; SINGLE NUCLEOTIDE POLYMORPHISM; CHILD; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; PRESCHOOL CHILD;

ADOLESCENT; ADULT; BAHRAIN; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HLA-DQ ANTIGENS; HUMANS; LINKAGE DISEQUILIBRIUM; LYMPHOTOXIN-ALPHA; MALE; POLYMORPHISM, GENETIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 40449107060     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00410-07     Document Type: Article

References (19)

1. Abiru, N., and G. S. Eisenbarth. 2000. Multiple genes/multiple autoantigens role in type 1 diabetes. Clin. Rev. Allergy Immunol. 18:27-40.
2. Al-Jenaidi, F. A., S. F. Wakim-Ghorayeb, A. Al-Abbasi, M. R. Arekat, N. Irani-Hakime, P. Najm, K. Al-Ola, A. A. Motala, and W. Y. Almawi. 2005. Contribution of selective HLA-DRB1/DQB1 alleles and haplotypes to the genetic susceptibility of type 1 diabetes among Lebanese and Bahraini Arabs. J. Clin. Endocrinol. Metab. 90:5104-5109.
3. Bouqbis, L., O. Akhayat, H. J. Garchon, F. Calafell, and H. Izaabel. 2003. TNFA-TNFB haplotypes modify susceptibility to type I diabetes mellitus independently of HLA class II in a Moroccan population. Tissue Antigens 61:72-79.
4. Cheong, K. Y., R. J. Allcock, P. Eerligh, C. S. Witt, F. T. Christiansen, V. McCann, and P. Price. 2001. Localization of central MHC genes influencing type I diabetes. Hum. Immunol. 62:1363-1370.
5. Cnop, M., N. Welsh, J. C. Jonas, A. Jorns, S. Lenzen, and D. L. Eizirik. 2005. Mechanisms of pancreatic beta-cell death in type 1 and type 2 diabetes: many differences, few similarities. Diabetes 54:S97-S107.
6. Deng, G. Y., N. K. Maclaren, H. S. Huang, L. P. Zhang, and J. X. She. 1996. No primary association between the 308 polymorphism in the tumor necrosis factor alpha promoter region and insulin-dependent diabetes mellitus. Hum. Immunol. 45:137-142.
7. Dotta, F., C. Fondelli, and U. Di Mario. 2005. Type 1 diabetes mellitus as a polygenic multifactorial disease: immunopathogenic mechanisms of beta-cell destruction. Acta Biomed. 76(Suppl. 3):14-18.
8. Fanning, G. C., M. Bunce, C. M. Black, and K. I. Welsh. 1997. Polymerase chain reaction haplotyping using 3′ mismatches in the forward and reverse primers: application to the biallelic polymorphisms of tumor necrosis factor and lymphotoxin alpha. Tissue Antigens 50 :23-31.
9. Fernandes Filho, J. A., C. A. Vedeler, K. M. Myhr, H. Nyland, and J. P. Pandey. 2002. TNF-α and -β gene polymorphisms in multiple sclerosis: a highly significant role for determinants in the first intron of the TNF- β gene. Autoimmunity 35:377-380.
10. Hajeer, A. H., and I. V. Hutchinson. 2000. TNF-alpha gene polymorphism: clinical and biological implications. Microsc. Res. Tech. 50:216-228.
11. Kockum, I., C. B. Sanjeevi, S. Eastman, M. Landin-Olsson, G. Dahlquist, and A. Lernmark. 1999. Complex interaction between HLA DR and DQ in conferring risk for childhood type 1 diabetes. Eur. J. Immunogenet. 26:361-372.
12. Kumar, R., R. Goswami, S. Agarwal, N. Israni, S. K. Singh, and R Rani. 2007. Association and interaction of the TNF-alpha gene with other pro- and anti-inflammatory cytokine genes and HLA genes in patients with type 1 diabetes from North India. Tissue Antigens 69:557-567.
13. McDevitt, H., S. Munson, R. Ettinger, and A. Wu. 2002. Multiple roles for tumor necrosis factor-α and lymphotoxin α/β in immunity and autoimmunity. Arthritis Res. 4:S141-S152.
14. Nishimura, M., H. Obayashi, I. Mizuta, H. Hara, T. Adachi, M. Ohta, H. Tegoshi, M. Fukui, G. Hasegawa, H. Shigeta, Y. Kitagawa, K. Nakano, R. Kaji, and N. Nakamura. 2003. TNF, TNF receptor type 1, and allograft inflammatory factor-1 gene polymorphisms in Japanese patients with type 1 diabetes. Hum. Immunol. 64:302-309.
15. Noble, J. A., A. M. Valdes, J. A. Lane, A. E. Green, and H. A. Erlich. 2006. Linkage disequilibrium with predisposing DR3 haplotypes accounts for apparent effects of tumor necrosis factor and lymphotoxin-alpha polymorphisms on type 1 diabetes susceptibility. Hum. Immunol. 67:999-1004.
16. Pociot, F., L. Briant, C. V. Jongeneel, J. Molvig, H. Worsaae, M. Abbal, M. Thomsen, J. Nerup, and A. Cambon-Thomsen. 1993. Association of tumor necrosis factor (TNF) and class II major histocompatibility complex alleles with the secretion of TNF-α and TNF-β by human mononuclear cells: a possible link to insulin-dependent diabetes mellitus. Eur. J. Immunol. 23: 224-231.
17. Rabinovitch, A., and W. L. Suarez-Pinzon. 2003. Role of cytokines in the pathogenesis of autoimmune diabetes mellitus. Rev. Endocr. Metab. Disord. 4:291-299.
18. Skeie, G. O., J. P. Pandey, J. A. Aarli, and N. E. Gilhus. 1999. TNFA and TNFB polymorphisms in myasthenia gravis. Arch. Neurol. 56:457-461.
19. Svejgaard, A., and L. P. Ryder. 1994. HLA and disease associations: detecting the strongest association. Tissue Antigens 43:18-27.